Do-Coop Technologies Reaches DMF and cGMP Milestones for Neowater(TM), its Proprietary Water-Based Nanotechnology
Published: May 07, 2007
BOSTON--(BUSINESS WIRE)--Do-Coop Technologies Ltd., a privately held corporation based in Israel, announced today that it has reached two significant milestones for Neowater™, its proprietary water-based nanotechnology. A Type IV Drug Master File has been submitted to the US Food and Drug Administration (FDA) for Neowater. In addition, the first Current Good Manufacturing Practice (cGMP) Neowater manufacturing plant is operational in Israel.